Since BCL-XL is frequently upregulated in HCC [20] and we found a stronger expression in Hep3B compared to Huh7 cells (Fig. 2A), we compared the efficacy of sorafenib combined with ABT-737 also in Huh7 cells. The gene discussed is BCL2L1; the disease is hepatocellular carcinoma.